- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07615478
Effect of Hot Spring Therapy on Central Fatigue Elimination During Altitude Training (HSCF-AHT)
22. maj 2026 opdateret af: Ziyue Ou, Macao Polytechnic University
A Randomized Controlled Trial Investigating the Effects of Hot Spring Therapy Balneotherapy on Central Activation, Cognitive Function, and Exercise Performance in Adolescent Rowers During Altitude Training
This randomized controlled trial investigates the effects of hot spring balneotherapy on central fatigue elimination in adolescent rowers undergoing altitude training at approximately 1600 meters (Tengchong, Yunnan).
Thirty adolescent athletes (aged 12-16 years) will be stratified by sex and randomly allocated to three groups: Group A (natural recovery, no immersion), Group B (38°C pure water immersion), and Group C (38°C sodium bicarbonate hot spring immersion).
Interventions will be administered 3 times per week for 4 weeks.
The primary outcomes are central fatigue indices including voluntary activation (VA) and central activation ratio (CAR).
Secondary outcomes encompass cognitive function (Stroop test, Psychomotor Vigilance Test), cerebral hemodynamics (functional near-infrared spectroscopy, transcranial Doppler ultrasound), exercise performance (maximal oxygen uptake, 1000m test, 500m test), blood lactate, and hematological parameters (white blood cells, neutrophils, platelets).
Studieoversigt
Status
Rekruttering
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Altitude training induces central fatigue characterized by decreased descending neural drive from the brain to skeletal muscle, reduced voluntary activation, and impaired cognitive function.
This study employs a stratified randomized block design to evaluate whether post-exercise hot spring immersion can accelerate central fatigue recovery compared to pure warm water immersion and natural recovery.
All participants will undergo standardized rowing training at approximately 1600 meters altitude.
Group C will receive immersion in natural hot spring water at 38°C for 20 minutes.
Group B will receive immersion in pure water at the same temperature and duration as a thermal control.
Group A will undergo standard training recovery without immersion.
The study incorporates partial blinding: Groups B and C are single-blinded to participants (identical appearance and protocol); Group A serves as an open-label control.
Assessments will be conducted at baseline (pre-altitude), mid-intervention (Week 2), end-intervention (Week 4), and follow-up (1-2 weeks post-altitude).
Undersøgelsestype
Interventionel
Tilmelding (Anslået)
27
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiekontakt
- Navn: Ziyue Ou, PHD
- Telefonnummer: +8615626121623
- E-mail: p2521734@mpu.edu.mo
Studiesteder
-
-
Macao
-
Macao, Macao, Kina
- Rekruttering
- Macao Polytechnic University
-
Kontakt:
- Ziyue Ou, PHD
- Telefonnummer: +8615626121623
- E-mail: p2521734@mpu.edu.mo
-
Kontakt:
- Ziyue Ou
- Telefonnummer: 15626121623
- E-mail: 105852022100090@stu.gzsport.edu.cn
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Barn
Tager imod sunde frivillige
Ja
Beskrivelse
Inclusion Criteria:
- Male or female aged 12-16 years- Healthy with no serious chronic diseases or skin conditions
- At least 1 year of systematic rowing training experience
- Currently undergoing centralized altitude training at approximately 1600 meters- No history of systematic hot spring or spa immersion within the past month
- No allergy history to sodium bicarbonate or hot spring minerals- Ability to provide written informed assent (participant) and written informed consent (parent/guardian)- No acute infection, fracture, or surgery within the past month
- Not currently taking non-steroidal anti-inflammatory drugs (NSAIDs), immunosuppressants, or medications affecting autonomic or cognitive function
Exclusion Criteria:
- History of cardiovascular, respiratory, renal, endocrine, or neurological disorders- Uncontrolled hypertension or hypotension
- History of syncope, heat intolerance, or severe dizziness during hot water immersion- Open wounds, severe eczema, or other skin conditions contraindicating water immersion
- Current use of beta-blockers, anticholinergics, stimulants, sedatives, or other medications affecting central nervous system function
- Color blindness or uncorrected visual impairment affecting Stroop test performance- Pregnancy (for female participants)- Alcohol consumption or smoking
- Shift work or trans-meridian travel within 2 weeks prior to baseline assessment
- Any condition deemed by the investigator as unsafe for participation
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: Natural Recovery Group
Participants in Group A will undergo standardized rowing training at approximately 1600 meters altitude for 4 weeks.
After each training session, participants will receive standard training recovery procedures without any water immersion intervention.
Recovery includes passive rest, self-directed light stretching, and ad libitum hydration in a thermoneutral environment (room temperature 24°C) for 20 minutes.
No thermal or hydrotherapy intervention will be provided.
|
Standard post-exercise recovery without water immersion.
Participants rest passively in a thermoneutral environment (24°C, 50-60% humidity) for 20 minutes with ad libitum water and optional self-directed stretching.
No heat, cold, or hydrotherapy interventions are applied.
Andre navne:
|
|
Aktiv komparator: Hot water immersion group
Subjects in Group B will undergo the same standardized rowing training at an altitude of approximately 1600 meters for 4 weeks.
After each training session, subjects will receive whole-body immersion (below the neck, with the head above water) in daily tap water at 38°C ± 0.5°C for 20 minutes.
The water temperature is monitored by a precision thermometer with an error of ≤ ±0.5°C.
The immersion is conducted in a standardized indoor facility, and the time is 16:00 on Tuesday, Thursday, and Saturday.
|
After exercise, full-body immersion in daily tap water.
Temperature: 38°C ± 0.5°C.
Duration: 20 minutes per session, 3 times per week (Tuesday, Thursday, Saturday at 16:00), for 4 consecutive weeks (total of 12 sessions).
Protocol: Full-body immersion below the neck for 20 minutes, followed by a 10-minute rest before leaving the facility.
Andre navne:
|
|
Eksperimentel: Hot Spring Immersion Group
Participants in Group C will undergo the same standardized rowing training at approximately 1600 meters altitude for 4 weeks.
After each training session, participants will receive full-body immersion (below neck, head above water) in natural hot spring water at 38°C ± 0.5°C for 20 minutes.
The spring water has a pH of approximately 7.4, Na+ content of 1210 mg/L, and HCO3- content of approximately 3300 mg/L.
Immersion will be performed in a standardized indoor facility on Tuesday, Thursday, and Saturday at 16:00, using the same protocol as Group B to maintain blinding.
|
After exercise, full-body immersion in natural hot spring water (pH approx.
7.4, Na+ 1210 mg/L, HCO3- approx.
3300 mg/L, total dissolved solids >1000 mg/L).
Temperature: 38°C ± 0.5°C.
Duration: 20 minutes per session, 3 times per week (Tuesday, Thursday, Saturday at 16:00), for 4 consecutive weeks (12 sessions total).
Protocol: Full-body immersion below the neck for 20 minutes, followed by a 10-minute rest before leaving the facility.
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Voluntary Activation
Tidsramme: Baseline (Week 0), Week 2, Week 3, Week 4 (post-intervention), Follow-up (Week 1-2 post-altitude)
|
Voluntary activation assessed by the interpolated twitch technique (ITT) during maximal voluntary contraction (MVC) of the quadriceps femoris using percutaneous electrical stimulation.
A single stimulus is superimposed on MVC; VA is calculated as: VA = (1 - superimposed twitch force / potentiated resting doublet force) × 100%.
Higher VA indicates greater central neural drive.
Unit: percentage (%).
|
Baseline (Week 0), Week 2, Week 3, Week 4 (post-intervention), Follow-up (Week 1-2 post-altitude)
|
|
Central Activation Ratio
Tidsramme: Baseline (Week 0), Week 2, Week 3, Week 4, Follow-up (Week 5-6 post-altitude)
|
Central activation ratio measured as the ratio of maximal voluntary contraction force to the force evoked by supramaximal electrical stimulation of the femoral nerve during quadriceps contraction.
CAR = MVC force / (MVC force + superimposed twitch force).
Values closer to 1.0 indicate less central fatigue.
Unit: ratio (0-1, no units).
|
Baseline (Week 0), Week 2, Week 3, Week 4, Follow-up (Week 5-6 post-altitude)
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Stroop Test Performance
Tidsramme: Baseline, Week 2,Week 4, Follow-up (Week 1-2 post-altitude)
|
Computerized Stroop Color-Word Test measuring executive function and cognitive inhibition.
Outcome variables: reaction time (ms) for congruent and incongruent trials, with interference effect calculated as incongruent minus congruent reaction time.
Administered in a quiet, temperature-controlled room (22-24°C).
Unit: milliseconds (ms).
|
Baseline, Week 2,Week 4, Follow-up (Week 1-2 post-altitude)
|
|
Cerebral Oxygenation
Tidsramme: Baseline, Week 2, fellow up
|
Changes in oxygenated hemoglobin (HbO2) and deoxygenated hemoglobin (Hb) in the prefrontal cortex during rest and cognitive tasks, measured by functional near-infrared spectroscopy (fNIRS) with a multichannel system.
Outcome: relative concentration changes (ΔμM) in HbO2 and Hb from baseline.
Unit: micromolar (μM).
|
Baseline, Week 2, fellow up
|
|
Psychomotor Vigilance Test
Tidsramme: Baseline, Week 2, Week 3, Week 4, Follow-up (Week 1-2 post-altitude)
|
5-minute Psychomotor Vigilance Test measuring sustained attention and psychomotor vigilance.
Outcome variables: mean response time, and number of lapses (reaction time >500 ms).
Administered via standardized software on a tablet/computer in a quiet environment.
Unit: milliseconds (ms).
|
Baseline, Week 2, Week 3, Week 4, Follow-up (Week 1-2 post-altitude)
|
|
Maximal Oxygen Uptake (VO2max)
Tidsramme: Baseline (Week 0), Follow-up (Week 5-6 post-altitude)
|
Maximal oxygen uptake measured during a graded exercise test on a rowing ergometer using a portable metabolic cart.
Protocol: incremental ramp test (starting at 100W, increasing 20W every 2 minutes) until volitional exhaustion.
Unit: mL/kg/min.
|
Baseline (Week 0), Follow-up (Week 5-6 post-altitude)
|
|
White Blood Cell Count (WBC)
Tidsramme: Baseline, Week 2, Follow up (Week 5-6 post-altitude)
|
Total white blood cell count measured from fasting venous blood sample using automated hematology analyzer.
Unit: 10^9 cells per liter (10^9/L).
|
Baseline, Week 2, Follow up (Week 5-6 post-altitude)
|
|
Neutrophil Count (NEUT)
Tidsramme: Baseline, Week 2, Follow-up (Week 5-6 post-altitude)
|
Absolute neutrophil count measured from fasting venous blood sample using automated hematology analyzer.
Unit: 10^9/L.
Baseline, Week 4 11 Platelet Count (PLT) Platelet count measured from fasting venous blood sample using automated hematology analyzer.
Unit: 10^9/L.
|
Baseline, Week 2, Follow-up (Week 5-6 post-altitude)
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Publikationer og nyttige links
Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.
Generelle publikationer
- Roerink ME, van der Schaaf ME, Dinarello CA, Knoop H, van der Meer JW. Interleukin-1 as a mediator of fatigue in disease: a narrative review. J Neuroinflammation. 2017 Jan 21;14(1):16. doi: 10.1186/s12974-017-0796-7.
- Goodall S, Gonzalez-Alonso J, Ali L, Ross EZ, Romer LM. Supraspinal fatigue after normoxic and hypoxic exercise in humans. J Physiol. 2012 Jun 1;590(11):2767-82. doi: 10.1113/jphysiol.2012.228890. Epub 2012 Apr 2.
- Ando S, Tsukamoto H, Stacey BS, Washio T, Owens TS, Calverley TA, Fall L, Marley CJ, Iannetelli A, Hashimoto T, Ogoh S, Bailey DM. Acute hypoxia impairs posterior cerebral bioenergetics and memory in man. Exp Physiol. 2023 Dec;108(12):1516-1530. doi: 10.1113/EP091245. Epub 2023 Oct 29.
- Koral J, Oranchuk DJ, Wrightson JG, Twomey R, Millet GY. Mechanisms of neuromuscular fatigue and recovery in unilateral versus bilateral maximal voluntary contractions. J Appl Physiol (1985). 2020 Apr 1;128(4):785-794. doi: 10.1152/japplphysiol.00651.2019. Epub 2020 Mar 12.
- Amann M, Sidhu SK, McNeil CJ, Gandevia SC. Critical considerations of the contribution of the corticomotoneuronal pathway to central fatigue. J Physiol. 2022 Dec;600(24):5203-5214. doi: 10.1113/JP282564. Epub 2022 Nov 23.
- Tamaoki S, Matsumoto S, Sasa N, Hoei T, Tojo R, Nakamura T, Aoyagi Y. Effects of sodium bicarbonate bath on the quality of sleep: An assessor-blinded, randomized, controlled, pilot clinical trial. Complement Ther Clin Pract. 2023 Feb;50:101714. doi: 10.1016/j.ctcp.2022.101714. Epub 2022 Dec 14.
- Grgic J, Pedisic Z, Saunders B, Artioli GG, Schoenfeld BJ, McKenna MJ, Bishop DJ, Kreider RB, Stout JR, Kalman DS, Arent SM, VanDusseldorp TA, Lopez HL, Ziegenfuss TN, Burke LM, Antonio J, Campbell BI. International Society of Sports Nutrition position stand: sodium bicarbonate and exercise performance. J Int Soc Sports Nutr. 2021 Sep 9;18(1):61. doi: 10.1186/s12970-021-00458-w.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Anslået)
25. maj 2026
Primær færdiggørelse (Anslået)
25. juni 2026
Studieafslutning (Anslået)
25. juni 2026
Datoer for studieregistrering
Først indsendt
19. maj 2026
Først indsendt, der opfyldte QC-kriterier
22. maj 2026
Først opslået (Faktiske)
29. maj 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
29. maj 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
22. maj 2026
Sidst verificeret
1. maj 2026
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 202502AS100005-2
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
UBESLUTET
IPD-planbeskrivelse
The project is still ongoing, and there are no current plans to contribute the data.
Whether to share it will be considered after the data is officially published.
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Kognitiv svækkelse
-
Uskudar UniversityRekrutteringAMCI - Amnestic Mild Cognitive ImpairmentTyrkiet (Türkiye)
-
Charité Neurocure AG FlöelUkendtAfasi | Anomi (ord-finding impairment)Tyskland
-
Dart NeuroScience, LLCAfsluttetAge-Associated Memory Impairment (AAMI)Forenede Stater
-
IRCCS San RaffaeleRekrutteringAlzheimers sygdom | MCI | AMCI - Amnestic Mild Cognitive Impairment | MCI Konvertering til demensItalien
-
Johns Hopkins UniversityNational Institute on Aging (NIA)RekrutteringSøvnforstyrrelser | AMCI - Amnestic Mild Cognitive ImpairmentForenede Stater
-
State University of New York at BuffaloAfsluttet
-
IRCCS San RaffaeleAktiv, ikke rekrutterendeMild kognitiv svækkelse (MCI) | Neurodegenerativ sygdom | Neurodegenerativ demens | AMCI - Amnestic Mild Cognitive ImpairmentItalien
Kliniske forsøg med Natural recovery
-
Hampton VA Medical CenterAfsluttetPersonlighedsforstyrrelser | Depression | Maniodepressiv | Stofbrugsforstyrrelser | PsykoseForenede Stater
-
Alcon ResearchAfsluttet
-
Istinye UniversityAfsluttet
-
Hospital de Clinicas de Porto AlegreUkendt
-
IC-IT Sciences Inc.UkendtSøvnforstyrrelserForenede Stater
-
Medical University of South CarolinaTrukket tilbageGrå stær | VisionForenede Stater
-
Recovery Record ResearchStanford UniversityAfsluttetBulimia nervosa | Spiseforstyrrelser | Binge Eating DisorderForenede Stater
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)AfsluttetTilbagevendende medulloblastom i barndommen | Tilbagevendende Ependymom | Tilbagevendende medulloblastomForenede Stater
-
University of NebraskaTrukket tilbage
-
Riphah International UniversityAfsluttetCervikogen hovedpinePakistan